W2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0geyBtYXgtd2lkdGg6IDEwMCU7IH0gW2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0gaW1nIHsgYm94LXNoYWRvdzogMXB4IDFweCAxMHB4IDVweCByZ2JhKCAwLCAwLCAwLCAwLjEgKTtib3JkZXItcmFkaXVzOiAwO2JhY2tncm91bmQtY29sb3I6IHJnYmEoIDI1NSwgMjU1LCAyNTUsIDEgKTtwYWRkaW5nOiAyMHB4O2JvcmRlcjogMHB4IHNvbGlkIHJnYmEoIDAsIDAsIDAsIDAuMjUgKTsgfSA=
W2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0geyBtYXgtd2lkdGg6IDEwMCU7IH0gW2RhdGEtdG9vbHNldC1ibG9ja3MtaW1hZ2U9ImYzN2UwMzE4MzUyYWY0NWU4NmQwNzAyOGRkNTA4M2Y3Il0gaW1nIHsgYm94LXNoYWRvdzogMXB4IDFweCAxMHB4IDVweCByZ2JhKCAwLCAwLCAwLCAwLjEgKTtib3JkZXItcmFkaXVzOiAwO2JhY2tncm91bmQtY29sb3I6IHJnYmEoIDI1NSwgMjU1LCAyNTUsIDEgKTtwYWRkaW5nOiAyMHB4O2JvcmRlcjogMHB4IHNvbGlkIHJnYmEoIDAsIDAsIDAsIDAuMjUgKTsgfSA=
GlycoMantra’s technology expertise is in glycobiology research leading to the development of carbohydrate-based therapeutics for treatment of advanced prostate cancer. The Company’s carbohydrate-based therapeutic drug, “GM101,” is expected to prevent cancer progression and metastasis in many cancers, particularly prostate adenocarcinoma.
